Other
Neoplasm by Site
CI-CAN-00000003Explore in graph →
Non-malignant20,485 active trials253 approved drugs3,567 evidence items
Loading cancer entity…
Other
CI-CAN-00000003Explore in graph →
Clinical trials
92,566 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04658589 | Laparoscopic vs. Open Distal Gastrectomy After Neoadjuvant Chemotherapy | not yet recruiting | N/A | 238 | Chonnam National University HospitalOTHER | 0 | Dec 8, 2020 | clinicaltrials |
| NCT04634448 | The Prevalence of Appendiceal Tumours in Periappendicular Abscess(PeriAPPAC-T) | not yet recruiting | N/A | 400 | Turku University HospitalOTHER_GOV | 0 | Nov 18, 2020 | clinicaltrials |
| NCT04451200 | Sequential and Personalized PK-guided Busulfan Administration in the Frame of the Conditiong Regimen for Allo-HSCT in Patients With Malignant Hemopathies Ineligible for the Standard Myeloablative Conditioning(BUSEQ) | not yet recruiting | Phase 2 | 82 | Institut Paoli-CalmettesOTHER | 0 | Nov 17, 2020 | clinicaltrials |
| NCT03848039 | Impact on Disease Relapse of HPV Vaccination in Women Treated With LEEP for Cervical Intraepithelial Neoplasia. HOPE9(HOPE9) | not yet recruiting | Phase 3 | 1,220 | Alessandro GhelardiOTHER | 0 | Nov 5, 2020 | clinicaltrials |
| NCT04616040 | A Real-world Study Evaluating the Usage of Camrelizumab in Chinese Patients With Advanced Esophageal Cancer | not yet recruiting | — | 1,030 | Peking UniversityOTHER | 1 | Nov 4, 2020 | clinicaltrials |
| NCT04599543 | IL3 CAR-T Cell Therapy for Patients With CD123 Positive Relapsed and/or Refractory Acute Myeloid Leukemia | not yet recruiting | Early Phase 1 | 36 | Zhejiang UniversityOTHER | 1 | Oct 27, 2020 | clinicaltrials |
| NCT04595162 | A Study of GC019F CAR-T Cell Immunotherapy for Relapsed or Refractory B- ALL | not yet recruiting | Phase 1 | 12 | Peking University Third HospitalOTHER | 0 | Oct 20, 2020 | clinicaltrials |
| NCT04515602 | Stratified Evaluation of PDS and NACT-IDS in Ovarian Cancer (FOCUS) | not yet recruiting | Phase 3 | 410 | Shanghai Gynecologic Oncology GroupOTHER_GOV | 1 | Aug 27, 2020 | clinicaltrials |
| NCT04520529 | Identification of Prognostic Factors and New Therapeutic Targets in Cutaneous Lymphomas(LYMPHOTEQ) | not yet recruiting | N/A | 500 | Assistance Publique - Hôpitaux de ParisOTHER | 0 | Aug 20, 2020 | clinicaltrials |
| NCT04465968 | Efficacy and Safety of CRT, Durvalumab and Surgery for SST(DEEP_OCEAN) | not yet recruiting | Phase 3 | 84 | National Cancer Center Hospital EastOTHER | 0 | Jul 10, 2020 | clinicaltrials |
| NCT04443543 | An Adaptive-design Prospective Cohort Study of Watch and Wait Strategy in Patients With Locally Advanced Rectal Cancer | not yet recruiting | Phase 2 | 222 | Fudan UniversityOTHER | 1 | Jun 30, 2020 | clinicaltrials |
| NCT04426136 | A Prospective Cohort Study Comparing Disparity in Surgical Procedure (Wide Local Excision Only vs Any Other Surgery Procedures) Among the Elderly Breast Cancer Patients | not yet recruiting | — | 300 | Peking Union Medical College HospitalOTHER | 1 | Jun 11, 2020 | clinicaltrials |
| NCT04338386 | Detection and Pathogenesis of Novel Protein F | not yet recruiting | — | 100 | Wuhan Asia Heart HospitalOTHER | 0 | Apr 10, 2020 | clinicaltrials |
| NCT04301739 | to Evaluate Efficacy and Safety of HLX10 in Combination With Chemotherapy Versus Placebo in Combination With Chemotherapy as Neoadjuvant Therapy and HLX10 Versus Placebo as Adjuvant Therapy in Patients With Triple Negative Breast Cancer (TNBC) | not yet recruiting | Phase 3 | 522 | Shanghai Henlius BiotechINDUSTRY | 0 | Mar 12, 2020 | clinicaltrials |
| NCT04301375 | Omission of Surgery and Sentinel Lymph Node Dissection in Clinically Low-risk HER2positive Breast Cancer With High HER2 Addiction and a Complete Response Following Standard Anti- HER2-based Neoadjuvant Therapy (ELPIS Trial)(ELPIS) | not yet recruiting | Phase 2 | 27 | David Garcia CincaOTHER | 1 | Mar 10, 2020 | clinicaltrials |
| NCT04227249 | 3 Year Recurrence Free Survival in Ultra-low-risk Endometrial Cancer(TREE PRO) | not yet recruiting | — | 153 | Seoul National University HospitalOTHER | 0 | Jan 14, 2020 | clinicaltrials |
| NCT04225858 | Avoiding Sentinel Lymph Node Biopsy in Breast Cancer Patients After Neoadjuvant Chemotherapy(ASICS) | not yet recruiting | N/A | 340 | The Netherlands Cancer InstituteOTHER | 0 | Jan 13, 2020 | clinicaltrials |
| NCT04168346 | Preoperative Intravenous Iron Therapy in Patients With Gastric Cancer(IRONSTOMACH) | not yet recruiting | Phase 4 | 202 | Helsinki University Central HospitalOTHER | 0 | Nov 19, 2019 | clinicaltrials |
| NCT04167332 | Prospective Collection of Samples for Urothelial Cancer of Bladder(ProCSUCaB) | not yet recruiting | — | 630 | Universitaire Ziekenhuizen KU LeuvenOTHER | 0 | Nov 18, 2019 | clinicaltrials |
| NCT04158856 | Adjuvant Dual Anti-HER2 Therapy in Patients With Small, Node-negative, HER2-positive Breast Cancer(SHERO) | not yet recruiting | Phase 2 | 60 | xuexin heOTHER | 0 | Nov 12, 2019 | clinicaltrials |
| NCT04153734 | Pembrolizumab + Platinum Doublets Without Radiation for Programmed Death-ligand 1 (PD-L1) ≥50% Locally Advanced NSCLC(Evolution) | not yet recruiting | Phase 2 | 21 | Kobe Minimally Invasive Cancer CenterOTHER | 0 | Nov 6, 2019 | clinicaltrials |
| NCT04093375 | Radical Prostatectomy Versus Radical Radiotherapy for Locally Advanced Prostate Cancer | not yet recruiting | N/A | 600 | Tongji HospitalOTHER | 0 | Oct 24, 2019 | clinicaltrials |
| NCT02990936 | Prognostic Impact of Tumor Growth Velocity in Head and Neck Squamous Cell Carcinoma Treated by Radio(Chemo)Therapy(TGV-PI) | not yet recruiting | — | 120 | Centre Hospitalier Universitaire UCLouvain NamurOTHER | 1 | Oct 3, 2019 | clinicaltrials |
| NCT04079699 | Predicting Prostate Cancer in Elderly Men | not yet recruiting | N/A | 700 | Odense University HospitalOTHER | 0 | Sep 6, 2019 | clinicaltrials |
| NCT04053231 | Hepatocarcinoma Recurrence on the Liver Study - Part2(HERCOLES2) | not yet recruiting | — | 3,000 | University of Milano BicoccaOTHER | 1 | Aug 12, 2019 | clinicaltrials |
| NCT04049422 | Pulmonary Nodule Cohort(liquidNodule) | not yet recruiting | — | 1,000 | Seoul National University HospitalOTHER | 0 | Aug 8, 2019 | clinicaltrials |
| NCT03975049 | Triplet Combination or Doublet Regimen Versus Chemoradiation as Neoadjuvant Therapy for Locally Advanced Rectal Cancer | not yet recruiting | Phase 3 | 933 | Sixth Affiliated Hospital, Sun Yat-sen UniversityOTHER | 0 | Jun 5, 2019 | clinicaltrials |
| NCT03923335 | The Predictive Value of Guangzhou Panel for Recurrence in Early-stage Colorectal Cancer | not yet recruiting | — | 287 | Sixth Affiliated Hospital, Sun Yat-sen UniversityOTHER | 1 | Apr 22, 2019 | clinicaltrials |
| NCT03880097 | Enabling the Study of Metabolism in Breast Cancer Through Collection of Fresh-tissue Biopsies(ENSEMBLE) | not yet recruiting | — | 240 | University College, LondonOTHER | 0 | Mar 19, 2019 | clinicaltrials |
| NCT03857737 | Endoscopic Submucosal Dissection Versus Surgery in the Treatment of Early Gastric Cancer | not yet recruiting | N/A | 300 | Peking University Third HospitalOTHER | 1 | Feb 28, 2019 | clinicaltrials |
| NCT03698721 | Urothelium Tissue Engineering Using Biopsies From Transurethral Resection of Prostate(IMOPU) | not yet recruiting | — | 365 | Central Hospital, Nancy, FranceOTHER | 0 | Oct 9, 2018 | clinicaltrials |
| NCT03358602 | Radiotherapy vs Neck Dissection for Clinical T1/2N0 Supraglottic Cancer | not yet recruiting | N/A | 158 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Dec 12, 2017 | clinicaltrials |
| NCT03367884 | Neck Dissection vs Radiotherapy for Cervical Metastases in Advanced Hypopharyngeal Cancer | not yet recruiting | N/A | 120 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Dec 12, 2017 | clinicaltrials |
| NCT03234179 | A Prognosis and Predicting Genetic Study of Lung Cancer | not yet recruiting | — | 500 | National Taiwan University HospitalOTHER | 0 | Aug 1, 2017 | clinicaltrials |
| NCT02785380 | Laparoscopic Surgery VS RFA for Recurrent HCC | not yet recruiting | Phase 4 | 340 | Sun Yat-sen UniversityOTHER | 0 | Jun 2, 2016 | clinicaltrials |
| NCT02779465 | Oral Vitamin D Treatment for the Prevention of Hepatocellular Carcinoma(VDHCC) | not yet recruiting | Phase 4 | 1,500 | Third Affiliated Hospital, Sun Yat-Sen UniversityOTHER | 0 | May 20, 2016 | clinicaltrials |
| NCT02497898 | Treatment of CIK for Patients With Refractory Non-Hodgkin Lymphoma | not yet recruiting | Phase 2 | 1,000 | The First People's Hospital of ChangzhouOTHER | 0 | Jul 15, 2015 | clinicaltrials |
| NCT02490735 | CIK in Treating Patients With Esophageal Cancer | not yet recruiting | Phase 2 | 2,000 | The First People's Hospital of ChangzhouOTHER | 0 | Jul 7, 2015 | clinicaltrials |
| NCT01595074 | Biomarkers in Predicting Treatment Response in Samples From Patients With Early-Stage Non-Small Cell Lung Cancer Previously Treated With Adjuvant Chemotherapy | not yet recruiting | — | 950 | National Cancer Institute (NCI)NIH | 1 | Sep 20, 2013 | clinicaltrials |
Data updated 22 days agoSource updated Dec 8, 2020source: clinicaltrials